While higher dietary magnesium is associated with improved insulin resistance, experts warn that supplement claims are often exaggerated, emphasising the importance of diet and lifestyle for metabolic health. The viral promise is neat enough to fit on social media: take…
A decade-long diabetes education initiative in Slovakia demonstrates a 57% lower risk of death among participants, highlighting the vital role of structured patient teaching in chronic disease management. A structured diabetes education programme in Slovakia has been linked with sharply…
The inaugural Trebinje Diabetes Forum emphasised that early diagnosis and personalised care are vital in preventing organ damage from diabetes, as healthcare professionals and patients came together for free tests, expert talks, and the latest management strategies. The first Trebinje…
Manufacturers of GLP-1 medications such as Ozempic and Wegovy face increasing lawsuits from patients claiming these drugs caused a rare eye condition that can lead to sudden vision loss, amid ongoing scientific debate about the true risks. Manufacturers of some…
A food engineer explains the distinctions between high- and lower-intensity sweeteners, highlighting how their unique properties influence health and sugar reduction strategies, amid mixed research findings. Sweeteners are often marketed as simple swaps for sugar, but food engineer Montse Meléndez…
An increasing wave of product liability lawsuits has emerged across the US, accusing makers of popular GLP-1 drugs like Ozempic and Wegovy of causing sudden, permanent vision loss due to NAION. While some countries update warning labels, US courts grapple…
Despite influencing flavour and texture, brown sugar provides minimal nutritional benefit compared to white sugar, with health considerations largely based on sugar quantity rather than type. Brown sugar often looks like a smarter choice than white sugar: darker, less polished…
Patients in the United States are initiating legal action against popular GLP-1 drugs, Ozempic, Wegovy, Mounjaro, and Zepbound, amid concerns over a rare but serious eye condition, nonarteritic anterior ischaemic optic neuropathy, raising safety questions about the diabetes and weight-loss…
A new study reveals that over a million Americans are receiving GLP-1 medicines without approved indications, spotlighting rising off-label prescribing, potential disparities, and safety questions amid a rapidly expanding market. A study published in the journal Obesity suggests that more…
A UCLA-led study reveals that insurance programmes like Medicaid and Medicare’s Low-Income Subsidy help improve medication adherence among Black and Hispanic Medicare Advantage enrollees, yet significant disparities remain, highlighting the need for targeted systemic and community-based solutions. A study led…
